Fennec Pharmaceuticals is trading at $11.82, down 5.06%, with the decline appearing primarily tied to global macro pressure as oil prices exceed $100 and U.S.-Iran tensions intensify.
- Major U.S. indices are down more than 0.5% in a broad risk-off session.
- No fresh company-specific announcement dated September 9, 2026 was identified.
- Latest company results, released August 11, showed strong quarterly growth.